Chemical Profiling and Bioactivity of Body Wall Lipids from Strongylocentrotus droebachiensis

Mar Drugs. 2017 Nov 24;15(12):365. doi: 10.3390/md15120365.

Abstract

The lipids from gonads and polyhydroxynaphthoquinone pigments from body walls of sea urchins are intensively studied. However, little is known about the body wall (BW) lipids. Ethanol extract (55 °C) contained about equal amounts of saturated (SaFA) and monounsaturated fatty acids (MUFA) representing 60% of total fatty acids, with myristic, palmitic and eicosenoic acids as major SaFAs and MUFAs, respectively. Non-methylene-interrupted dienes (13%) were composed of eicosadienoic and docosadienoic acids. Long-chain polyunsaturated fatty acids (LC-PUFA) included two main components, n6 arachidonic and n3 eicosapentaenoic acids, even with equal concentrations (15 μg/mg) and a balanced n6/n3 PUFA ratio (0.86). The UPLC-ELSD analysis showed that a great majority of the lipids (80%) in the ethanolic extract were phosphatidylcholine (60 μg/mg) and phosphatidylethanolamine (40 μg/mg), while the proportion of neutral lipids remained lower than 20%. In addition, alkoxyglycerol derivatives-chimyl, selachyl, and batyl alcohols-were quantified. We have assumed that the mechanism of action of body wall lipids in the present study is via the inhibition of MAPK p38, COX-1, and COX-2. Our findings open the prospective to utilize this lipid fraction as a source for the development of drugs with anti-inflammatory activity.

Keywords: COX; GC-MS; UPLC-ELSD; body wall lipids; inhibition of p38 MAPK; sea urchin.

MeSH terms

  • Animals
  • Aquatic Organisms
  • Cell Line / drug effects
  • Cyclooxygenase Inhibitors / chemistry*
  • Cyclooxygenase Inhibitors / pharmacology
  • Gas Chromatography-Mass Spectrometry
  • Lipids / chemistry*
  • Lipids / pharmacology
  • Sea Urchins*
  • Strongylocentrotus / chemistry*

Substances

  • Cyclooxygenase Inhibitors
  • Lipids